XML 17 R4.htm IDEA: XBRL DOCUMENT v3.24.3
Condensed Consolidated Statements of Income (Unaudited) - USD ($)
shares in Thousands, $ in Thousands
 3 Months Ended 9 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Sep. 30, 2024
Sep. 30, 2023
Revenues        
Total revenues $ 290,084 $ 216,033 $ 717,316 $ 599,214
Operating expenses        
Cost of sales 49,426 54,823 117,362 140,063
Amortization of intangibles 17,762 20,341 53,287 56,011
Research and development 18,458 17,321 58,607 55,027
Selling, general and administrative 41,241 35,269 112,086 111,574
Total operating expenses 126,887 127,754 341,342 362,675
Operating income 163,197 88,279 375,974 236,539
Other income (expense)        
Investment and other income, net 6,474 4,786 16,499 10,957
Contingent liability fair value measurement gain 0 13,200 0 13,200
Interest expense (4,524) (4,505) (13,555) (13,542)
Income before income tax expense 165,147 101,760 378,918 247,154
Income tax expense 28,136 19,923 71,839 50,948
Net income $ 137,011 $ 81,837 $ 307,079 $ 196,206
Earnings per share        
Basic (usd per share) $ 1.08 $ 0.62 $ 2.42 $ 1.48
Diluted (usd per share) $ 1.05 $ 0.61 $ 2.37 $ 1.45
Weighted average common shares outstanding        
Basic (in shares) 126,850 131,965 126,969 132,896
Diluted (in shares) 130,134 134,083 129,526 135,233
Royalties        
Revenues        
Total revenues $ 155,061 $ 114,433 $ 400,572 $ 325,813
Product sales, net        
Revenues        
Total revenues 86,659 86,569 224,128 221,252
Revenues under collaborative agreements        
Revenues        
Total revenues $ 48,364 $ 15,031 $ 92,616 $ 52,149